Canada has a tradition of healthcare innovations

  • The electron microscope opened a whole new level of sub-microscopic examination
  • The discovery of Insulin keeps an estimated 13 million Americans alive on a daily basis
  • Pablum™ continues to provide infants all their daily required daily nutrients
  • The discovery of Stem cells to fight various cancers and neurodegenerative diseases
  • Flibanserin, the “female Viagra” was patented by a Canadian!

“As a small country, we certainly need to double down in the areas where our strengths align with growing global market demand…medicine is just one such example.”

Ilse Treurnicht, CEO of MaRS Discovery District (September 22, 2015)

Mammoth’s goal is to apply proven innovation models to Canadian healthcare innovations:

“Joint ventures (JV) between start-ups with limited resources and big companies with those resources…(makes)…all the difference in the rate of commercialization, and the degree of commercial success.”

Dr. Bruce Merrifield, Professor Emeritus, Wharton School of Business, Assistant Secretary of the US Department of Commerce for Technology, & Under Secretary for Economic Affairs (1981-1989), found in “Partnering for Progress, BIRD:30 Years of Collaboration, 1977-2007”

Hospital gurney

FACT

In 2014 there were approximately 350 Canadian health innovations in Ontario alone.

CN Tower
Hospital equipment
Hospital equipment

“I remain bullish on Canada. Canadians are capable of creating national wealth when we approach prosperity systematically and strategically.”


Jim Balsillie, past Co-Chairman of RIM, May 8, 2015

The following is a very short list of potential Mammoth JV candidates:

  • Early detection tool for cognitive impairments common in Alzheimer & dementia
  • New MRI contrast agents less toxic and more potent than current approved agents
  • Rapid, low-cost point-of-care blood analysis
  • Surgical suite system to review digital images through hand gestures
  • Enabling device for incapacitated patients to use touch screens
  • Use of sound therapy already proven to reduce tinnitus to improve sleep quality
  • Use of bacterial cellulose based composites for development of vascular grafts
  • Mechanical rapid infusion device for use in emergency situations
  • Enterprise class cloud connected patient monitor to improve post-surgical success
  • Automated patient scheduling for follow-up and specialist appointments

International Strategic Relationships

Our primary strategic partnership is with Launch NY based in Buffalo, NY.

Launch NY (www.launchny.org) is Upstate NY's only nonprofit, 501(c)(3) Venture Development Organization (VDO) and Community Development Financial Institution (CDFI) venture fund. They are the most active seed fund in Upstate NY region since 2016 (Launch NY Seed Fund LLC) and were recently awarded the first CDFI designation for the Fund. Since 2012 they have provided over 750 startups with expert pro bono mentoring through 18 Entrepreneurs-in-Residence & National Mentor Network. With Mammoth they are focused on further developing the growing Healthcare and Health IT sectors in the Upstate NY region.

Additionally, Mammoth has established strategic relationships with a number of US-based hospitals and universities with a reputation for creating innovative healthcare solutions.

What’s in it for those participating:

Health IT companies

The US government is a new market for this segment under Special Identification Number (SIN) 132-56. This applies to Health IT companies both in the USA and the 124 countries covered by the Trade Agreement Act (TAA).


Universities

The Universities in the Mammoth network will provide work experience for their Masters and PhD students and create a launch pad for Healthcare Innovation leaders for generations to come.

Large Global Partners

Large Global Partners will have access to healthcare innovations that provide enhanced features or fill voids in their product lines plus a “first rights of refusal” at exit.


The Donors

Launch NY Healthcare IT Fund LLC (the “Fund”), is a single-member LLC owned and controlled by LNY. Any contribution to the efforts of the Fund will be in the form of a donation, with donors provided a tax deductible receipt. No returns are offered through this Fund to donors. All returns will be used to reinvest in the Upstate NY ecosystem.